Indeed, we confirmed elevated CEP55 levels in different HCC cohorts and showed that CEP55 overexpression correlated with poor patient survival and early cancer recurrence (Fig. 4A/B, Suppl. The gene discussed is CEP55; the disease is hepatocellular carcinoma.